Abstract: A composition and medicament comprising the cis-9, trans-11 isomer of conjugated linoleic acid for treating inflammatory diseases, including asthma, is provided. A method for inhibiting the proliferation of human or animal cells of the immune systems involved in an immune response including administering the cis-9, trans-11 isomer of conjugated linoleic acid to a patient is also provided. A nutritional, functional food, or dietary supplement including the cis-9, trans-11 isomer of conjugated linoleic acid is also provided.

Abstract: The disclosed invention relates to the use of esters of unsaturated, physiologically active fatty acids as nutrient media for cell cultivation and, more particularly, as a substitute for foetal bovine serum. In one aspect, the esters comprise more than 50 mol-% of physiologically active fatty acids containing 16 to 24 carbon atoms and 2 to 5 double bonds as the acid component and a lower C1-4 alcohol, preferably ethanol, or a sterol as ester component. In another aspect, the esters comprise a transesterification product of natural or synthetic oils or a mixture of such oils having greater than 50 mol-% of unsaturated, physiologically active fatty acids, based on the acyl group, and a lower C1-4 alcohol or a sterol. In a further aspect, the esters are used together with sterols, phospholipids and/or vegetable proteins or are liposomally encapsulated.

Abstract: A composition and medicament comprising the cis-9, trans-11 isomer of conjugated linoleic acid for treating inflammatory diseases, including asthma, is provided. A method for inhibiting the proliferation of human or animal cells of the immune systems involved in an immune response including administering the cis-9, trans-11 isomer of conjugated linoleic acid to a patient is also provided. A nutritional, functional food, or dietary supplement including the cis-9, trans-11 isomer of conjugated linoleic acid is also provided.

Abstract: The invention describes a process for the production of glycerol of providing a vegetable oil or fat as starting material, obtaining crude glycerol from the vegetable oil or fat, and treating the crude glycerol with a reducing agent. The present invention also describes a process for the production of a medicament or pharmaceutical composition, the medicament or composition formed by combining glycerol and at least one pharmaceutically active ingredient. The present invention also describes a pharmaceutical composition or medicament composed of glycerol obtained by way of the invention and a pharmaceutically active ingredient, which compositions forms very little glyceraldehyde and dihydroxyacetone during storage.

Abstract: The disclosed invention relates to the use of esters of unsaturated, physiologically active fatty acids as nutrient media for cell cultivation and, more particularly, as a substitute for foetal bovine serum. In one aspect, the esters comprise more than 50 mol-% of physiologically active fatty acids containing 16 to 24 carbon atoms and 2 to 5 double bonds as the acid component and a lower C1-4 alcohol, preferably ethanol, or a sterol as ester component. In another aspect, the esters comprise a transesterification product of natural or synthetic oils or a mixture of such oils having greater than 50 mol-% of unsaturated, physiologically active fatty acids, based on the acyl group, and a lower C1-4 alcohol or a sterol. In a further aspect, the esters are used together with sterols, phospholipids and/or vegetable proteins or are liposomally encapsulated.

Abstract: This disclosure relates to a heat or cold storage composition comprising at least one continuous and at least one discontinuous phase, the continuous phase being liquid or at least plastic at a temperature of ?10 to 50° C. and the discontinuous phase—present in the continuous phase—being particulate and containing as phase change material (PCM) at least 10% by weight of an organic compound with a melting point of 0 to 50° C. and at least one structuring polymeric compound. It also relates to the use of a composition according to the invention for controlled heating/cooling by phase change and to a device for the controlled heating/cooling of an object by phase change at least comprising a container for holding a composition according to the invention.

Abstract: Processes for preparing conjugated fatty acid products are described wherein (a) a composition which comprises a fatty acid ester having at least two unconjugated, carbon-carbon double bonds is provided; (b) the fatty acid ester is conjugated in the presence of a water-free base; (c) phosphoric acid is added to the conjugated fatty acid ester such that phosphate salts are precipitated; and (d) the precipitated phosphate salts are removed.

Abstract: Compositions comprising at least one conjugated linoleyl alcohol component selected from the group consisting of cis- and trans-isomers of 6,8-octadecadienol, 7,9-octadecadienol, 8,10-octadecadienol, 9, 11-octadecadienol, 10,12-octadecadienol and 11,13-octadecadienol are described along with their use in oral and topical applications for humans and animals.

Abstract: A process for making a purified glycerol carbonate involving: (a) providing a mixture of crude glycerol carbonate, wherein said mixture contains glycerol carbonate, glycerol and oligomeric glycerol carbonate; (b) providing a substantially water-free base component; (c) reacting the mixture with the base component to form a reaction mixture; and (d) filtering the reaction mixture to form the purified glycerol carbonate.

Abstract: Processes for preparing conjugated fatty acid products are described wherein (a) a composition which comprises a fatty acid ester having at least two unconjugated, carbon-carbon double bonds is provided; (b) the fatty acid ester is conjugated in the presence of a water-free base; (c) phosphoric acid is added to the conjugated fatty acid ester such that phosphate salts are precipitated; and (d) the precipitated phosphate salts are removed.

Abstract: Processes for preparing linoleic acid raw materials are described wherein the processes comprise: (a) transesterifying a triglyceride component with an alcohol having from 1 to 4 carbon atoms, at a temperature of from 80 to 120° C., to form a transesterification mixture comprising linoleic acid esters and one or more by-products selected from the group consisting of glycerides, free glycerol, and soaps, wherein the triglyceride component is comprised of at least 60% by weight linoleic acid; and (b) removing the one or more by-products from the transesterification mixture.

Abstract: Processes for preparing linoleic acid raw materials are described wherein the processes comprise: (a) transesterifying a triglyceride component with an alcohol having from 1 to 4 carbon atoms, at a temperature of from 80 to 120° C., to form a transesterification mixture comprising linoleic acid esters and one or more by-products selected from the group consisting of glycerides, free glycerol, and soaps, wherein the triglyceride component is comprised of at least 60% by weight linoleic acid; and (b) removing the one or more by-products from the transesterification mixture.